Mt. Vesuvius, Inc. - Redux The recent reveal of us

New Post Public Reply Private Reply Replies (1) Message Board
WBeacham
502
Mt. Vesuvius, Inc. - Redux

The recent reveal of us (BIEL) having a signed contract w/ the Dept of Veterans Affairs has largely gone unnoticed, oddly enough. The whole situation puzzles me, lots of contradictions and questions. This throws a huge monkey wrench into any kind of projections of revenue, profit, upcoming deals, you name it and this reveal puts everything into a weird & wacky, what-the-hell-is-going-on kind of whirling dervish conundrum. This puts everything back on the table and in no particular order. What's next?

The first thing is the term of the contract, from 2019 to 2024. So, we signed it sometime in 2019. 2019 !?!?!? Which means we were negotiating it sometime in 2018. Biel got full body FDA clearance in Feb. 2020. How does that date fit in w/ us signing a major contract in year 2019 and in late stage negotiations in 2018? Was there some kind of deal already in the works prior to the FDA clearance? I have been forever writing about what would happen if (if, if, if, ...) we ever got a deal w/ the VA. And now I find out we already had one? I mean, WTF ???

I reviewed the Chairman letter of 10 Aug 2020. In the section entitled "The Last 10 Months’ Activities" not a peep about a 5 yr contract w/ The Dept of Veterans Affairs which just so happens to be the largest integrated healthcare system in the United States with approx'ly 1,300 VA facilities in the US providing medical services to 7,000,000 veterans. In fact, not a peep about anything related to involvement w/ the federal gov't. About 10% of vets report severe, consistent chronic pain. Clearly, a huge unaddressed market that is tailor made for RecoveryRx and no mention of it? This was no oversight. This was deliberate. The obvious question is why. What is happening or is about to happen?

When will Biel announce the contract? Not b4 adequate supply has been produced and distributed. Run the numbers. Let's say we provide a 100 pack of RecoveryRx to each facility. That's 1,300,000 devices at $5 a pop; $6.5 million. Or 700,000 vets w/ severe, persistent might require 5 devices per year. That's $16.5 million. And don't forget surgeries. Substantial revenue + all other revenue streams.

Is Medicare/Medicaid far behind if we are in the federal registry, so to speak? Think of all the hurdles we jumped thru to get this done not to mention the secrecy involved. No wonder nobody's talking. What will be the impact on the share price should a press release come out w/ we are supplying the entire Veterans Administration? Look what happened when we clarified the Q2 #'s; 330+ million shares traded & 26% share price increase in one day. The announcement could come at any time. What is the holdup is the real question. This would overshadow any OEM partnership currently on the books, hands down, seriously turbo-charging the share price to way beyond the penny threshold.

We had to know thru our own due diligence about the volume we would be expected to produce to fulfill the contract. We were in the middle of negotiations in 2018 (presumably). This was before the scamdemic was let loose on the sheeple and a chip shortage ensued. If we were sitting at the table w/ VA in 2018, and we were, then that is plenty of time to notify CICD Tech of upcoming demands on the manufacturing, b4 the chip shortage. Are we still trying to play catch-up or is something more brewing?

In closing, finally!, I'm confused, but in a good way. It will be interesting to see how this situation is revealed/handled when the time comes. I have fixated on insurance this whole time not realizing we had a signed contract w/ the Veterans Admin, in my mind, one of the premier events that "might conceivably occur" when, in fact, it was a done deal the whole time. Now what do I do? Two (2) yrs into it and ... crickets. Besides what we already know ref: OEM partners, what else might we expect? If I replace my fixation on insurance w/ the VA contract, is a buyout on the table b/c we have FDA clearance and a very lucrative, long-term contract w/ the VA? Is there any doubt we are at the table with, as CEO Kelly, said, the big boys? None whatsoever.

a VA contract, whodathunkit? - WBeacham

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aspen Dental Brings Comprehensive Care to Whiteville

Updated Category News Views 6

Bringing Dentistry Closer to Home Now, Whiteville's dental game just got a power-up, with Aspen Dental setting up shop in town. This isn't just another practice popping up—it's a full-on dental hub offering everything from regular cleanings to emergency tooth fixes. And let’s face it, this area's diverse population needs it. The Man Behind the Chair Guess who’s at...

Continue Reading
Striveworks: Boosting Army's AI Edge in Indo-Pacific

Updated Category News Views 6

The world keeps marching forward, and here’s Striveworks stepping up to the plate with another big move in the military tech space. This isn't your average partnership renewal; this involves a five-year, $200 million deal to enhance battlefield AI as the U.S. Army hones its modern warfare edge in the Indo-Pacific. Now, this isn't just a battle of strategies but a battle...

Continue Reading
PrideStaff: 8 Years Strong on Franchise Times Top 400

Updated Category News Views 4

Where PrideStaff Stands in the Franchise Landscape Here's something the staffing world can't ignore: PrideStaff nailed it again, landing among the giants on the Franchise Times Top 400 for the eighth straight year. Sitting at number 217, this ain't just a lucky streak—this is a sustained homerun, my friends. Consistency Is Key, And They're Holding It Consider this...

Continue Reading
Webull Faces Legal Scrutiny Over Chinese Ties

Updated Category News Views 5

The Unfolding Drama for Webull Shareholders When you see a ticker like NASDAQ:BULL rolling off your tongue these days, it’s not just about stock prices anymore—it's a whole saga wrapped in legal and geopolitical spice. Following the recent uproar from a House China committee report, Webull found itself thrust into the spotlight for all the wrong reasons. That report...

Continue Reading
Lupin Secures FDA Nod for Key Injectable Drug

Updated Category News Views 4

Lupin's FDA Approval: A Strategic Play in Pharmaceuticals Ah, the thrill of a new approval! Lupin Limited has landed U.S. FDA approval for their Phytonadione Injectable Emulsion, marking a significant stride into the lucrative realm of vitamin K treatments. This approval isn't just a feather in Lupin's cap—it's a calculated move to corner a piece of the estimated $52.3...

Continue Reading
Raken Debuts Change Orders: A Game-Changer for Builds

Updated Category News Views 4

Construction Gets a Streamlined Boost with Raken's New Tool In construction, chaos often partners seamlessly with progress. But Raken is stepping in to shake things up a bit. This isn’t just another run-of-the-mill software update; this is Raken flexing its muscles in the construction tech arena. They’ve rolled out Change Orders, enhancing their project management...

Continue Reading
Hexaware Teams with Anthropic for Game-Changing AI Move

Updated Category News Views 4

A Bold AI Partnership on the Horizon Mutual back-slapping or a deal with authentic grit? Hexaware’s latest tango with Anthropic might just be the jolt enterprises need. Announced under the flickering fluorescent lights of Mumbai, London, and Iselin, Hexaware’s multi-year partnership with Anthropic thrusts Claude, their razor-sharp AI, right into the mix of...

Continue Reading
Ajman Tourism Department Hits Internal Audit Milestone

Updated Category News Views 4

A Nod to Standards in Ajman's Tourism Department Folks, it's not every day you see a government department get this kind of spotlight in the internal audit arena, yet here we are. The Ajman Department of Tourism, Culture and Media has snagged Full Conformance with Internal Audit Quality Standards. That’s not just some random feather in their cap but a signal flare in...

Continue Reading
Rutter Mills Secures $13M in Virginia Injury Cases

Updated Category News Views 4

The Stakes in Virginia When you drop nine successful injury cases on the scales and they tip over $13 million, that's a story worth dissecting. The two top dogs at Rutter Mills certainly know how to make a splash in the legal puddle, don't they? We're talking about attorneys Adam H. Lotkin and Georgina D. Montgomery here, the legal eagles behind these jaw-dropping...

Continue Reading
Ardelyx Securities Fraud Suit: Key Investor Moves

Updated Category News Views 5

Fraud Allegations: Ardelyx Under the Microscope Looks like Ardelyx has found itself neck-deep in trouble, facing a class action lawsuit over alleged securities fraud. This isn't just a storm in a teacup. We're talking about accusations of false and misleading statements tied to their commercial performance—statements that might have left investors holding the bag with...

Continue Reading

Top 5 Most Recently Viewed Articles

Justin Parks Steps Up as Senior VP: A.B. Data's Growth Strategy

Updated Category News Views 211

Justin Parks Elevates A.B. Data as Senior Vice President A.B. Data, a renowned provider of class action notice and claims administration services, has made a significant announcement regarding the promotion of Justin Parks to Senior Vice President. In this vital role, he is set to enhance A.B. Data's Class Action and Incident Response sales strategies, thereby deepening...

Continue Reading
Ken Kendrick: A Journey of Resilience and Recognition

Updated Category News Views 609

Ken Kendrick’s Recognition by the Horatio Alger Association Ken Kendrick, the managing general partner of the Arizona Diamondbacks, has recently been honored by the Horatio Alger Association, which has selected him for its Member Class of 2025. This prestigious recognition is awarded to individuals who have overcome personal and professional adversities, showcasing...

Continue Reading
Weave Partners with Affordable Care to Transform Patient Services

Updated Category News Views 199

Weave and Affordable Care: A Game-Changer for Dental Practices In today's competitive healthcare landscape, enhancing patient experience and operational efficiency is paramount. Recently, Affordable Care made a significant decision in choosing Weave as the go-to platform for patient communications, engagement, and payments. This strategic partnership aims to revolutionize...

Continue Reading
Gilat Advances Connectivity in Peru with New $25 Million Deal

Updated Category News Views 110

Gilat's New Agreement Enhances Connectivity in Peru Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a frontrunner in satellite networking technology, recently announced a significant stride towards digital inclusion in Peru through a $25 million agreement signed by its Peruvian subsidiary, Gilat Perú. This contract was established with Pronatel, Peru’s...

Continue Reading
Technip Energies Shows Impressive Growth in Nine-Month Results

Updated Category News Views 178

Technip Energies Financial Performance Overview Technip Energies 9M 2025 Financial Results A company focused on sustainable growth Technip Energies, recognized for its innovative approach to engineering and technology in the energy sector, has reported a commendable performance for the first nine months of 2025. The company emphasizes its role in energy transition and...

Continue Reading